NASDAQ:TRUPTrupanion Stock Price, Forecast & News

Trupanion's stock was trading at $26.04 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, TRUP shares have increased by 130.7% and is now trading at $60.08.
View which stocks have been most impacted by COVID-19.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Trupanion in the last year. There are currently 5 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Trupanion.

Trupanion is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Trupanion.

Trupanion Inc (NASDAQ:TRUP) issued its earnings results on Tuesday, August, 4th. The financial services provider reported $0.04 earnings per share for the quarter, beating the consensus estimate of ($0.01) by $0.05. The financial services provider had revenue of $117.92 million for the quarter, compared to the consensus estimate of $114.63 million. Trupanion had a return on equity of 1.19% and a net margin of 0.38%. The company's revenue was up 27.9% on a year-over-year basis. During the same period in the previous year, the firm posted ($0.06) earnings per share.
View Trupanion's earnings history.

8 analysts have issued 12-month target prices for Trupanion's stock. Their forecasts range from $20.00 to $67.00. On average, they expect Trupanion's share price to reach $45.43 in the next twelve months. This suggests that the stock has a possible downside of 24.4%.
View analysts' price targets for Trupanion.

Media headlines about TRUP stock have trended very negative this week, InfoTrie Sentiment reports. InfoTrie scores the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Trupanion earned a media sentiment score of -3.2 on InfoTrie's scale. They also assigned news stories about the financial services provider a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the next several days.
View the latest news about Trupanion.

Trupanion saw a decrease in short interest during the month of July. As of July 31st, there was short interest totaling 7,360,000 shares, a decrease of 8.2% from the July 15th total of 8,020,000 shares. Based on an average daily volume of 370,900 shares, the days-to-cover ratio is presently 19.8 days. Currently, 25.6% of the company's stock are sold short.
View Trupanion's Short Interest.

Some companies that are related to Trupanion include UnitedHealth Group (UNH), Anthem (ANTM), Cigna (CI), Humana (HUM), Centene (CNC), Molina Healthcare (MOH) and Advanzeon Solutions (CHCR).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Trupanion investors own include CA (CA), Micron Technology (MU), Chipotle Mexican Grill (CMG), McEwen Mining (MUX), Pfizer (PFE), Abbott Laboratories (ABT), BlackRock (BLK), NVIDIA (NVDA), AbbVie (ABBV) and Endologix (ELGX).

Trupanion trades on the NASDAQ under the ticker symbol "TRUP."

Trupanion's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Goldman Sachs Group Inc. (1.44%), Palisade Capital Management LLC NJ (0.89%), Global Endowment Management LP (0.85%), PNC Financial Services Group Inc. (0.45%), Karani Asset Management LLC (0.37%) and Bank of New York Mellon Corp (0.31%). Company insiders that own Trupanion stock include Asher Bearman, Dan Levitan, Darryl Rawlings, Gavin Friedman, H Hays Lindsley, Howard E Rubin, Margaret Tooth, Murray B Low, Robin A Ferracone and Tricia Plouf.
View institutional ownership trends for Trupanion.

TRUP stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Thomas Story & Son LLC, First Trust Advisors LP, Great Lakes Advisors LLC, US Bancorp DE, Karani Asset Management LLC, RMB Capital Management LLC, and Banque Cantonale Vaudoise. Company insiders that have sold Trupanion company stock in the last year include Asher Bearman, Dan Levitan, Darryl Rawlings, Gavin Friedman, H Hays Lindsley, Margaret Tooth, Murray B Low, Robin A Ferracone, and Tricia Plouf.
View insider buying and selling activity for Trupanion.

TRUP stock was acquired by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., PNC Financial Services Group Inc., Frontier Capital Management Co. LLC, EAM Investors LLC, Epoch Investment Partners Inc., Integrated Advisors Network LLC, Palisade Capital Management LLC NJ, and Global Endowment Management LP.
View insider buying and selling activity for Trupanion.

Shares of TRUP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of TRUP stock can currently be purchased for approximately $60.08.

Trupanion has a market capitalization of $2.12 billion and generates $383.94 million in revenue each year. The financial services provider earns $-1,810,000.00 in net income (profit) each year or ($0.05) on an earnings per share basis. Trupanion employs 586 workers across the globe.

The official website for Trupanion is www.trupanion.com.

Trupanion's mailing address is 6100 4TH AVENUE SOUTH SUITE 200, SEATTLE WA, 98108. The financial services provider can be reached via phone at 855-727-9079 or via email at [email protected]